Podcasts about resmed

Casiñanos analiza los valores de Indra, Santander, Sarepta Therapeutics,Resmed y Nvidia, entre otros

As July wraps up, all eyes turn to August reporting season, where investors are bracing for modest earnings growth and heightened volatility. Banks, staples and tech stocks face valuation pressure, while retailers and miners contend with weaker demand and rising costs. Expect capital management, cost control and forward guidance to separate the standouts from the strugglers.In this week's wrap, Grady covers:(0:11): the pivot away from the financial sector(1:38): a dive into the technology, retail, healthcare and materials sectors(3:21): key risks to watch out for this reporting season(4:12): how the market performed this week so far(4:47): the most traded stocks and ETFs this week(5:14): economic news items to look out for.

MARKET WRAP: ASX200: down 0.3% to 8,709 GOLD: $3,363 USD/oz BITCOIN: $179,152 CSL advancing 1.5%, to $269.56 Sonic Healthcare and Resmed were also higher. Clarity pharmaceuticals jumped 10% to $4.31 Fortescue's shares rose by 4.3% to $19 after it announced a record volume of iron ore shipments and projected stronger growth. Lynas Rare Earths gained more than 5% to $10.65 Bapcor saw its shares plummet by 28% to $3.66 after it saw weaker sales over the last couple of months. Northern Star Resources dipped by 2.4% Also falling backwards was BHP, Wesfarmers and Macquarie Group AUD/USD: 66.2 US Cents AUD/GBP: 48.9 British Pence AUD/EUR: 56 Euro Cents AUD/JPY: 97 Yen AUD/NZD: $1.09 NZSee omnystudio.com/listener for privacy information.

What happens when you need to rebrand thousands of physical products across global markets? For companies like Logitech and ResMed, changing a logo isn't just about updating a website - it's about retooling manufacturing lines, redesigning packaging for millions of units, and navigating complex regulatory requirements.Join brand leaders Paige Lutter from Logitech and John Barger from ResMed as they share their experiences leading brand strategy for physical product companies. Learn how Logitech solved their global naming challenges with the "Logi" mark, how ResMed approaches branding medical devices, and why both companies treat AI as a utility rather than a branded feature.Key insights include:Managing brand architecture across hardware, software, and digital touchpointsStrategies for implementing brand changes across global product linesThe critical role of executive support in brand transformationBuilding authentic customer connections through physical brand touchpointsBalancing innovation with brand consistency in regulated industriesWhether you're working with physical products or digital experiences, this conversation offers valuable lessons on brand strategy, change management, and the power of patience in building lasting brand value.

Investors weighed inflation data as the consumer price index rose 0.1% in May from April, less than the 0.2% estimate from economists were expecting. Core CPI, which strips out volatile food and energy prices, also increased 0.1%, less than expected. All three major US benchmarks closed lower. The Dow Jones lost 1.1%, the S&P500 lost 0.27%, following a 3- day winning streak, while the Nasdaq closed down 0.5%.European markets were mixed as focus remains on the US - China trade discussions, which occurred this week in London. Germany's DAX is down 0.16%, France's CAC down 0.36%, the FTSE100 was in the green, up 0.13%, while the STOXX600 closed 0.27% lower.Yesterday, the Australian market gained 0.06% by the close, with real estate, energy and materials sectors leading the market's gains. On the other end, information technology was the biggest mover, declining 1.5%, so keep watch of tech stocks today, with the Nasdaq also lower overnightWhat to watch today:The SPI futures are suggesting that our local market will open 0.23% higher this morning, however the futures lost earlier gains this morning, following reports that the US are preparing to partially evacuate the Iraq embassy over regional security.In economic data, consumer inflation expectations will be out at 11:00am this morning.And in commodities:Crude oil has rallied 4.9% trading at US$68.15 per barrel, after President Donald Trump announced a preliminary trade deal with China, raising hopes for stronger energy demand. The agreement includes China supplying rare earth minerals and the US easing restrictions on Chinese students, however final approval is still pending.Gold has gained 1% trading at US$3,363And iron ore is up 0.3% at US$95.78 per tonne.Trading ideas:Bell Potter have maintained their Buy rating on marketing and communications business IVE Group (ASX:IGL) and have increased their price target by 7% to $3.00 as the broker expects a positive trading update and upgrade in FY25 guidance. At the current share price of $2.66 this implies 12.8% share price growth in a year.And Trading Central have identified a bullish signal in ResMed (ASX:RMD) indicating that the stock price may rise from the close of $39.02 to the range of $44.50 to $45.75 over 36 days, according to the standard principles of technical analysis.

US equities closed mixed overnight. The Dow Jones dropped 0.2%, ending at four day winning streak as lower than expected payroll data dragged down sentiment. The S&P500 and the Nasdaq however, both closed in the green, gaining 0.44% and 0.32% respectively.European markets were all in the green with the STOXX600 up 0.47%.Our local market rallied yesterday as the energy sector lead the market with strong gains. Paladin Energy (ASX:PDN) and Mineral Resources (ASX:MIN) were among the top performers.Uranium stocks jumped at the open following news that one of the world's biggest technology companies had stepped up demand for nuclear power.The rise came after Meta overnight signed a 20-year contract to buy 1,121 megawatts from Constellation's nuclear plant, with power supply beginning in 2027. This follows similar deals struck by peers Microsoft, Amazon, and Google parent Alphabet. Nuclear power has emerged as one of the biggest winners from the AI-fuelled surge in electricity needed for data centres. New nuclear reactors are an important source of uranium demand growth. This follows Microsoft's recent deal to fulfil all AI power needs from a US Nuclear power plant.Also yesterday, the GSP growth rate was released. GDP grew at 0.2% in the March quarter following a 0.6% expansion in the prior quarter. Markets were expecting a 0.4% rise so the data out today indicating stalled growth.What to watch today:The Australian market is set to open slightly in the red. The SPI futures are suggesting a 0.1% drop at the open this morning.And in commodities,Crude oil has dropped more than 1% and is trading at US$62.69 per barrel as Saudi Arabia signalled it may push for a large production increase, raising fears of a global oil oversupply.The price of gold has rebounded, advancing 0.6% trading at US$3,373.44 an ounce, and approaching a one-month high, as a series of weak US economic reports renewed concerns over the outlook.And iron ore has jumped more than 1% trading at US$96.26 per tonne. The price is still hovering around eight- month lows as weak economic data from China clouded the metal's demand outlook.Trading ideas:Bell Potter maintain their Buy rating on Elders (ASX:ELD), a leading supplier to fertiliser, agricultural chemicals and animal health products. Their 12- month price target is unchanged at $9.10, and at ELD's current share price of $6.15, this implies 48% share price growth in a year.And Trading Central has identified a bullish signal in ResMed (ASX:RMD) indicating that the stock price may rise from the close of $38.33 to the range of $40.60 - $41.20 over 10 days according to the standard principles of technical analysis.

A credit rating downgrade of the US hurt the Australian share market, but how significant is it for investors? MARKET WRAP: ASX200: up 0.58%, 8343 GOLD: $3,229 US/ounce BITCOIN: $163,965 AUD Technology One, which posted a 33% increase in profit to $81.9 million, shares up 11.3% to $36.76. Wistech rising 2.7% and Life360 up 1.6%. Commbank again hitting fresh highs at $172.43. Wesfarmers, Goodman Group and Telstra all finished higher. Regis Resources down 1.1% to $4.55. Utilities stocks were lower again, with Origin, APA Group and AGL all down. Falling by more than 1% were Northern Star, Resmed and Fisher & Paykel Healthcare. CURRENCY UPDATE: AUD/USD: 64.2 AUD/GBP: 48 pence AUD/EUR: 57 Euro cents AUD/JPY: 93 yen AUD/NZD: 1.09 Dollars See omnystudio.com/listener for privacy information.

For today's episode of Buy or Sell, Adam Keily is joined by William Mumford, Deputy Portfolio Manager at Auscap Asset Management. Here are some of the names Adam and Will cover in today's episode:ResmedCSLNick ScaliCAR groupSeekReliance WorldwideBHPRio TintoCommonwealth BankHomeCo Daily Needs REITAnd if you want to hear more from Adam Keily, make sure you check our Comedian v Economist (Apple | Spotify).In Comedian v Economist, Adam is joined by his brother Thomas, a former RBA economist, to break down the macroeconomic stories of the week.In their most recent episode they spoke about Trump's tariffs on Liberation Day, the latest jobs data, what falling liquor sales can tell us about the economy and the collapse in the market for second-hand Teslas.—------Sign up to our daily news email to get the news moving markets delivered to your inbox at 6am every weekday morning. Short, sharp, to the point, it'll get you up to speed in less than 5 minutes.—------Want more Equity Mates?Listen to our basics-of-investing podcast: Get Started Investing (Apple | Spotify)Watch Equity Mates on YouTubePick up our books: Get Started Investing and Don't Stress, Just InvestFollow us on social media: Instagram, TikTok, & LinkedIn—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

Woodside will kick off a huge new project in the US, but will this lead to better earnings in a sector that’s been under pressure? MARKET WRAP: ASX200: up 0.92% to 8,070 GOLD: $3,354 US/oz BITCOIN: $147,858 AUD Mineral Resources shares closed 13.2% higher to $20.57 after saying it would cut its output of iron ore Boss Energy jumped 14.3% higher to $3.20 Fortescue’s shipping of 46.1 million tonnes of iron ore across the three-month period, sent shares up 5.8% to $16.37. Northern Star downgrading its full-year gold output guidance – with shares down 4.7%. Auckland International Airport shares 4% lower Going backwards were Woolworths, Resmed, and James Hardie CURRENCY UPDATE: AUD/USD: 64.3 US cents AUD/GBP: 47.9 pence AUD/EUR: 56 Euro cents AUD/JPY: 91 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

The ASX 200 got another boost before the second long weekend in the row, as the air of volatility starts to subside.See omnystudio.com/listener for privacy information.

"Down cycles are not fun. But they form the basis for enormous future profitability” - Steve SchwarzmanAfter a couple of wild weeks in markets, this week has been a little calmer. The Trump administration has turned its focus to other priorities as the world holds its breathe during the 90-day tariff pause. That is, aside from China, who are pulling out all stops to get the upper hand in this trade war. In today's episode we unpack:How China is using TikTok as a tool in the trade war Meta gets its day in court in its antitrust caseOur views on the latest housing policies by both sides of politics Some of the stocks that are falling into our watch list —------Want to get involved in the podcast? Record a voice note or send us a message —------Keep up with the news moving markets with our daily newsletter and podcast (Apple | Spotify)—------Want more Equity Mates? Across books, podcasts, video and email, however you want to learn about investing - we've got you covered.—------Looking for some of our favourite research tools?Find company information on TIKRScreen the market with GuruFocusResearch reports from Good ResearchTrack your portfolio with Sharesight—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

Collins Foods will offload Taco Bell, but can it be blamed on the rise of Guzman y Gomez? MARKET WRAP: ASX200: up 0.17% to 7,761 GOLD: $3,246 US/oz BITCOIN: $135,130 AUD Collins shares down almost 8% to $8.00, while rival GYG falling 0.3% to $33.40. Evolution Mining hit a record high today up just under 4% to $8.21 CSL had a healthy day up 2.6% to $244.10 but still well off its 52 week high of $313.55. Resmed also a touch higher The big 4 banks were all higher led by Westpac up 0.8% to $30.76. BHP and RIO both up with Fortescue the standout up 0.8% to $15.32 Treasury Wine stocks fell 3.4% to $8.30. Wesfarmers marginally weaker to $74.21 Aristocrat Leisure also fell 1.2% to $62.21. Star Entertainment released its half year results, posting a loss of $300 million for the half. CURRENCY UPDATE: AUD/USD: 63.6 US cents AUD/GBP: 48.1 pence AUD/EUR: 56 Euro cents AUD/JPY: 91 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

A deal for De Grey mining looks even certain of getting done, at a time where the gold price is surging to even higher prices. MARKET WRAP: ASX200: up 1.34%, 7,748 GOLD: $3,242 US/oz BITCOIN: $133,593 AUD Neuren Pharmaceuticals rising by 21% to $11.13 as they got FDA approval on a trial to treat childhood disorders. DroneShield stock jumped 16% to $1.03 after securing $32 million in contracts with an Asian military ally. Gold stocks shined following a long term broker upgrade on the gold price. Newmont jumped more than 4% to $87.04. De Grey Mining also got a boost of 1.6% after Gold Road Resources, a minority investor, supported the $5 billion takeover bid from Northern Star. Resmed closed down just under 2% to $33.61 A2 Milk shares fell by 3% to $8.06 Telstra which is still within a few cents of its 52 week high fell just 2 cents to $4.43 CURRENCY UPDATE: AUD/USD: 63.3 US cents AUD/GBP: 48.0 pence AUD/EUR: 58 Euro cents AUD/JPY: 90 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

“Are you okay?” That was the question Emma Fisher got from her mum after the ASX plunged more than 6% in a single day. For Fisher, it was a soft signal that the worst of the panic may be behind us. In this episode of The Rules of Investing, Emma shares why sharp sell-offs are the new normal, the two market “buckets” she's buying from, and how she's funding new ideas. Last time she was on the podcast, Emma tipped ResMed at $22. This time, she's back with a fresh idea she's backing for the next 5 years. _____________________ Thanks to our Sponsor AlphaSense This latest episode is brought to you by AlphaSense. See what AlphaSense can do for your investment research—visit alpha-sense.com/livewire to get started.

Dear Listeners, Welcome back to the Primary Medicine Podcast! Today's guest is Ron Richard, a true healthcare innovator with over 35 years of experience in respiratory, pulmonary, and sleep medicine. From launching over 40 medical products and holding 15 patents to working with industry leaders like ResMed and Qualcomm, Ron has helped shape the future […] The post Episode 105: From Bedside to Breakthrough: Ron Richard on Innovation and Invention appeared first on Primary Medicine Podcast.

Vice President of Product Management at ResMed Charles Hartson chats with Michael around the benefits of a good nights sleep.See omnystudio.com/listener for privacy information.

MARKET WRAP: ASX200: up 0.83%, 7,854 GOLD: $2,997 US/oz BITCOIN: $131,789 AUD BHP gained 2.4%, Fortescue rising 4.2%, and Rio Tinto up 1.8%. Mineral Resources was another miner getting a bump after a UBS upgrade of the company saw it gain more than 11% to $24.49 Confirmation of a merger between Spartan Resources and Ramelius Resources sent Spartan 9.1% higher – Ramelius going the other way by 0.9% The oil price pushing back over US $71 a barrel helped Woodside gain 1.9%. Most of the big banks finished higher, but NAB fell 0.2% to $33.24 after it announced changes to its executive team. Losses were felt in the Healthcare sector.. CSL dropped 0.9% and Resmed fell 1.3%. Telstra, Woolworths and Coles all down CURRENCY UPDATE: AUD/USD: 63.37 US cents AUD/GBP: 48.9 pence AUD/EUR: 58 Euro cents AUD/JPY: 94 Japanese yen AUD/NZD: 1.09 NZ dollars See omnystudio.com/listener for privacy information.

Donald Trump’s tariff plans have sent fear through currency markets, so how much will it affect Australia? MARKET WRAP: ASX200: down 0.91%, 7,890 GOLD: $2,904 US/oz BITCOIN: $127,794 AUD The local ASX couldn’t hold back the tide, dropping another 0.9% or 72 points to 7890 – a low not seen since mid-August last year. Only defensive areas like Utilities, Energy & Consumer Staples in positive territory. Life 360, which is also listed on Wall Street, tumbled 8.7%, Xero was down 5.1%, Technology One suffered by 5.7% and Wisetech shed 1.9%. A block trade by investors of Nickel Industries was the reason it fell almost 20% to 60 cents a piece. Ramelius Resources will spend almost $100 million on upgrades to its Mt Magnet mill, seeing shares down 17.2% to $2.31. Commonwealth Bank – another drop of 0.8% sending shares down to $146.92. Westpac, NAB and ANZ bucked the market trend to finish ahead. Utility stocks gained ground, with Origin up 1.4% and APA Group up 1.9% BHP up 1.2%, Woodside stronger by 1.2% and Resmed surging 3%. CURRENCY UPDATE: AUD/USD: 62.81 US cents AUD/GBP: 48.7 pence AUD/EUR: 57 Euro cents AUD/JPY: 92 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

BHP has made yet another move to expand into copper, in what could be a hedge against iron ore price fluctuations. MARKET WRAP: ASX200: up 0.18%, 7,962 GOLD: $2,920 US/oz BITCOIN: $130,189 AUD Woodside gained 1.9%, Yancoal was up 2.5% and Whitehaven rose 3.5%. BHP looks headed to Africa to search for copper, signing a deal with an explorer & development company and gaining half a percent. Gains of more than 1% for Computureshare, QBE and Resmed. A mixed day for the banks saw Commbank, NAB and Westpac all finishing lower. Johns Lyng group will be removed from the ASX 200 index, sending its shares down another 12.5% to $2.45. And Star Entertainment is still not trading, but is considering a rescue offer from a US-based casino Group. CURRENCY UPDATE: AUD/USD: 63.17 US cents AUD/GBP: 48.9 pence AUD/EUR: 58 Euro cents AUD/JPY: 93 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

With Donald Trump’s new tariff program hitting China hard, will Australia’s iron ore miners suffer in the process? MARKET WRAP: ASX200: down 0.58% to 8,198 GOLD: $2,903 US/oz BITCOIN: $134,474 AUD An oil price resulted in a 3.2% fall across Energy stocks, with Woodside falling over 3%, Santos was down 4.7%, and Ampol shed almost 2%. The threat of Cyclone Alfred saw insurers Suncorp and QBE both down 2%, while IAG was off by 1.7%. Origin dropped 4.2% and Nick Scali fell 3.9% as both traded ex-dividend. Qantas made it over $10 for the first time, rising 2.1% to $10.20. Health Care’s good day was led by CSL rising 1% and Resmed lifting 0.9%. Gains of more than 1% for Transurban, Evolution Mining, and Mirvac. CURRENCY UPDATE: AUD/USD: 62.06 US cents AUD/GBP: 48.9 pence AUD/EUR: 59 Euro cents AUD/JPY: 92 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

From Pickwickian Syndrome to Sleep Disordered Breathing, Obstructive Sleep Apnea, OSA, and everything in between. Well it all started with a vacuum cleaner!Meet Dr Peter Farrell, founder and former CEO of Resmed; the little company we all know very well! Dr Farrell tells about his time in university in Australia, then at MIT, and finally meeting with Dr Collin Sullivan to develop the first commercially available CPAP machine. Learn the fascinating origin story of the CPAP and how Resmed grew from 9 people to the 10,000 person multinational company we know today. For more information vistit resmed.comA huge thanks to our sponsors:Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/Don't forget to Like, Share, Comment, and Subscribe!Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 94Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP

Buy or Sell with Adam Keily is back for 2025! In our first episode, Adam is joined by Adam Dawes, Senior Investment Adviser at Shaw & Partners. Tune in to hear Adam's take on the following companies:IFL PLS BWP AMC EIQ XROJBH RMDEVNALL—------Want to get involved in the podcast? Record a voice note or send us a message on our website and we'll play it on the podcast.—------Sign up to our daily news email to get the news moving markets delivered to your inbox at 6am every weekday morning. Short, sharp, to the point, it'll get you up to speed in less than 5 minutes.—------Want more Equity Mates?Listen to our basics-of-investing podcast: Get Started Investing (Apple | Spotify)Watch Equity Mates on YouTubePick up our books: Get Started Investing and Don't Stress, Just InvestFollow us on social media: Instagram, TikTok, & LinkedIn—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Dr. Maria Artunduaga, the founder and CEO of Samay, a startup that's using acoustic energy to get a clearer picture of the lung's performance. Family tragedy and professional frustration set Dr. Artunduaga on a course that won MedTech Innovator's Grand Prize. She has the giant check to prove it. This episode was sponsored by DeviceTalks Boston. You can register at Boston.DeviceTalks.com. Rachel Robinson, COO of MassMEDIC, joins us on the Newmarker's Newsmakers. Before we hit the news of the week, Robinson gave a preview of the upcoming MassMEDIC's Symposium & Gala on March 6. Go to MassMEDIC.com for more information. MassDevice Executive Editor Chris Newmaker then delivers news on - Boston Scientific, ResMed, Globus Medical, BD and Baxter. Hilarity ensues. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.

Trump’s tariffs tanked global markets, but could there be some ASX-listed entities that benefit from the global trade fall out. MARKET WRAP: ASX200: down 1.79%, 8,379 GOLD: $2,819 US/oz BITCOIN: $155,130 AUD Fisher & Paykel Healthcare said its cost pressures would increase from the Mexican tariffs, sending its shares down 7.4% to $31.80 CSL was down 1.8%, Pro Medicus fell 3% and Resmed dropped 3.1%. A reduction in full-year guidance from Westgold after slower-than-expected progress on its mines saw its shares losing 12.4% to $2.26 Fortescue down 4.4%, NAB shed 2.3% and Wesfarmers dropped 1.9%. KMD Brands rose 4.1% to 38 cents a share Regis Resources established a $300 million credit facility, sending its shares almost 2% higher. Telstra, Yancoal, and Seek swam against the tide to finish higher. CURRENCY UPDATE: AUD/USD: 61.40 US cents AUD/GBP: 49.9 pence AUD/EUR: 59 Euro cents AUD/JPY: 95 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

On episode 502 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews Ron Richard, BBA, a medical device consultant, inventor, and author with a long track record of successfully developing and launching dozens of medical products. In the course of their conversation, Keith and Ron discuss how nurses and other healthcare professionals can leverage their expertise as consultants and inventors in the sphere of medical device development. Mr. Richard has been employed in the medical industry for over thirty-five years and has extensive knowledge and experience in respiratory, pulmonary and sleep medicine. He began his medical career working in a respiratory department at a large teaching hospital in the Midwest. Upon leaving the medical center, Ron became involved in owning and operating home care companies, sleep laboratories, manufacturers and distribution businesses. In addition to these experiences he was instrumental in developing and designing several products used in the treatment and diagnosis of chronic health care conditions. In the course of his career, Mr. Richard has launched over 40 major products resulting in sales over $1B. He has held senior level positions with Nellcor Puritan Bennett, Thermo Electron, ResMed, Qualcomm, SeQual Technologies and several other companies in sleep and respiratory care sectors. Having graduated from Baker University with a degree in Business Administration, he also holds certificates in respiratory care and emergency medicine, and has been awarded 15 patents and multiple industry awards due to his focus and dedication to improving health care outcomes. Mr. Richard also enjoys writing music and performing live concerts around the country and has played over 500 shows over the past 10 years. In 2021 he published a new book, Someday is Today! Get your Ideas out of your coffee cup and on the market, containing experiential information pertaining to FDA, patents, raising capital, team formation, sales, marketing and product launches. Connect with Ron Richard: InventingStartsToday.com LinkedIn Someday is Today on Amazon Contact Nurse Keith about holistic career coaching to elevate your nursing and healthcare career at NurseKeith.com. Keith also offers services as a motivational and keynote speaker and freelance nurse writer. You can always find Keith on LinkedIn. Are you looking for a novel way to empower your career and move forward in life? Keith's wife, Shada McKenzie, is a gifted astrologer and reader of the tarot who combines ancient and modern techniques to provide valuable insights into your motivations, aspirations, and life trajectory, and she offers listeners of The Nurse Keith Show a 10% discount on their first consultation. Contact Shada at TheCircelandtheDot.com or shada@thecircleandthedot.com.

In this episode of Investor Connect, we dive into two distinct yet promising sectors: medical diagnostics and sleep technology. Michael Cormack from Corwin Medical elaborates on the company's efforts to tackle peripheral artery disease (PAD) through innovative diagnostic systems that leverage multi-element ultrasound arrays and AI-based algorithms. He elaborates on the severe impact of PAD, its high mortality rate, and the cumbersome nature of current diagnostic tools like the Doppler Pencil Probe. Michael outlines their unique Ultrasense system, which promises faster, more accurate diagnostics, detailing a robust business model and strong leadership geared towards high-margin revenue and strategic industry partnerships with entities like Medtronic and Philips. He highlights the company's commercialization timeline and financial trajectory towards profitability by 2026, supported by a strong patent portfolio and seed funding efforts. The compelling patient stories and strong market need underscore the critical importance of their work in early PAD detection and intervention.  Following this, we turn our focus to SleepScore Labs with Colin Lawlor, who shares his journey from ResMed to founding an organization dedicated to leveraging AI and data for improving consumer sleep. Recognizing sleep's critical role in overall health, Colin outlines how SleepScore Labs utilizes proprietary sleep data and intervention studies to provide companies with actionable insights and personalized coaching solutions. The importance of sleep for mitigating chronic diseases and optimizing wellness drives their market opportunity, particularly through B2B2C models with partners like Mattress Firm and Terabody. By highlighting their success in Germany, where their platform is reimbursed by insurance without a doctor's prescription, Colin emphasizes the robust, scalable business model ready to capitalize on the growing demand for sleep solutions.  The episode closes with both Cormack and Lawlor discussing their exit strategies and potential for partnerships with industry giants, illustrating the potential for innovation in medical diagnostics and sleep technology. The detailed exploration into these fields gives investors and entrepreneurs critical insights into the paths to market success and the transformative potential of these cutting-edge technologies. Team and Funding 30:14 Q&A and Conclusion

In our final 2024 episode of the DeviceTalks Weekly podcast, ResMed CEO Mick Farrell shares the company's strategy for reaching the billions of people who need help sleeping, breathing and remaining healthy. He talks with Host Tom Salemi about the company's connectivity capabilities, response to wearable technology, and its take on a rival's recall. This episode is sponsored by Aptyx. Go to www.Aptyx.com to learn more. We'll also bring you the Newsmakers of 2024 brought to you by DeviceTalks Managing Editor Kayleen Brown as well as our Editorial Team - Editor Chris Newmarker, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley, and Jim Hammerand, managing editor of Medical Design and Outsourcing. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

There has been a lot of VR news lately. We'll get caught up on the world of Nate's Apple Vision Pro, Dave's Meta Quest, and Samsung is getting into the game with Apple. Are you on the VR bandwagon yet? Plus, we've got all of the other segments, tech news, tips, and picks to help you tech better! Watch on YouTube! INTRO (00:00) Amazingly Awkward Christmas Playlist (04:10) MAIN TOPIC: Apple, Meta, Google VR News (10:05) Tim Cook defends Vision Pro's sales performance with three words Popular Science Innovation of the Year - Apple Vision Pro Simply Piano now lets you learn to play through Apple Vision Pro — no keyboard required ResMed debuts ergonomic head strap for Vision Pro Blackmagic debuts $30,000 3D camera for capturing video for Vision Pro Apple Vision Pro has completely changed how Porsche unveils sports cars in two ways Latest Meta Quest 3 update includes a major visual overhaul, and improved PCVR This Vision Pro clone from Samsung and Google is good news for Apple users DAVE'S PRO-TIP OF THE WEEK:  Return of the volume slider on the Lock Screen (28:30) JUST THE HEADLINES: (34:00) Scrabble star wins Spanish world title – despite not speaking Spanish X gains a faster Grok model and a new ‘Grok button' Startup will brick $800 emotional support robot for kids without refunds LG stops making Blu-ray players Australia struggling with oversupply of solar power Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion YouTube TV Hikes Price $10 to $82.99 TAKES Tips pour in over 5,000 drone sightings. Reason to worry? Government says no (40:20) Artificial intelligence is helping archaeologists unlock Earth's oldest secrets (44:00) T-Mobile opens registration for Starlink direct-to-cell satellite service beta launch (45:55) An official statement from Peak Design regarding privacy (46:55) BONUS ODD TAKE: Open the microwave door game (49:15) PICKS OF THE WEEK: Dave: Bambu Lab A1 Combo (52:15) Nate: 32 Inch Webcam Stand Camera Mount, Upgraded Thick Base Flexible Gooseneck Camera Stand Desk Webcam Mount Clamp for Logitech Webcam C930e C930 C920 C922x C922 Brio 4K C925e C615, Gopro Hero 8 7 6 5 4 (01:00:25) RAMAZON PURCHASE - Giveaway! (01:03:05) Find us elsewhere: https://notpicks.com - Find links to previous picks of the week https://www.notnerd.com - All things Notnerd

The merger between Chemist Warehouse and Sigma looks closer than ever after the companies gave an update to the market today. MARKET WRAP: ASX200: down 0.75%, 8,193 GOLD: $2,612 US/oz BITCOIN: $134,135 AUD Nine of the eleven sectors were in the red, with tech stocks again the biggest loser Wisetech slid 3% to $121.79, and Xero down 1.4% to $168.62. South32 dropping 4.4% to $3.52 after saying escalating problems in Mozambique had affected transport to its operations. ANZ, Rio Tinto and Santos were all down by more than 1%. Higher real estate stocks were led by Goodman, up 1.7% and Stockland, up 2.2%. While also lifting were Wesfarmers, Pro Medicus and Resmed. CURRENCY UPDATE: AUD/USD: 64.74 US cents AUD/GBP: 49.9 pence AUD/EUR: 60 Euro cents AUD/JPY: 96 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

ANZ will bring in an ex-HSBC Portuguese banker to fill their vacant CEO role, but will investors warm to the appointment? MARKET WRAP: ASX200: up 0.03%, 8,423 GOLD: $2,671 US/oz BITCOIN: $155,084 AUD ANZ CEO Shayne Elliott stepping down after nine years in the role; shares down 3.6% to $30.03. GQG Partners gained 6.3% to $2.21 after reporting higher funds under management through November. Discretionary stocks got a boost, with Breville up 2.9%, and GYG lifting 1.1%. Also up over 1% was Commbank and Resmed. A fall in the oil price didn't help the Energy sector, with Woodside down 1.1% and Santos dropping 0.8%. Life360 dropped 8.3% to $24.03 as its listing on the US indices faced some challenges. BHP, Fortescue and Rio Tinto all down.   CURRENCY UPDATE: AUD/USD: 64.15 US cents AUD/GBP: 50.30 pence AUD/EUR: 60.8 Euro cents AUD/JPY: 96 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

  MARKET WRAP: ASX200: up 0.37%, 8,224 GOLD: $2,557 US/oz BITCOIN: $139,317 AUD The ASX 200 broke a losing streak to close up 0.4% Accounting software company Xero released its half-year earnings with shares finishing 5.9% higher to $171. Farm chemical supplier Nufarm saw its shares gain 6% despite a 29% fall in underlying earnings. Commbank up 2.2%, NAB up 1%, Westpac up 1.3% and ANZ up 1.2%. BHP down 1.3% and Fortescue down 1.9%. Resmed down 2.5% and Bluescope Steel down 2.4%. CURRENCY UPDATE: AUD/USD: 64.65 US cents AUD/GBP: 51.0 pence AUD/EUR: 61 Euro cents AUD/JPY: 100 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

HMC Capital is the latest company to get in on the data centre craze, with the trend set to continue with the rise of AI. MARKET WRAP: ASX200: down 0.35%, 8,266 GOLD: $2,678 US/oz BITCOIN: $123,353 AUD BHP dropping 4.1% to $41.63, Fortescue down 7.3% to $18.12, and Rio Tinto falling 3.1% to $119.47. HMC Capital saw shares rising 4% after revealing plans to launch a data centre investment trust on the ASX Battery tech provider Novonix rallied 12.5% as it signed a supply deal with a US auto company. Goodman Group gained 2.5% and Resmed was up 1.9%. Lower sales for Endeavour saw its shares dropping by 4.9% to $4.50. Backwards by more than 1% was Pro Medicus, Seek and APA Group. CURRENCY UPDATE: AUD/USD: 65.84 US cents AUD/GBP: 51.03 pence AUD/EUR: 61.5 Euro cents AUD/JPY: 101 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

ResMed (RMD) CEO Mick Farrell joins Morning Trade Live to discuss the company's latest earnings beat. ResMed primarily focuses on sleep apnea and COPD. He talks about GLP-1 medications and consumer tech offering medical monitoring like the Apple (AAPL) Watch. He discusses the customer base for ResMed and its hardware vs software businesses. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

The Qantas board has avoided a second strike on its remuneration report as its share price hit a record so Mahnaz Angury spoke with Upstream Aviation Analyst Tim Collins to find out if its reputation is being repaired; Rhayna Bosch discusses the future of AI and the implication of GLP-1 drugs like Ozempic with ResMed CEO Michael Farrell; and SBS Finance Editor Ricardo Gonçalves looks through the day's market news with Isaac Poole from Oreana Group.

ResMed's leadership in sleep apnea stems from the combination of its digital-health ecosystem and new hardware to pair with smartwatches and wearables, CEO Mick Farrell tells Bloomberg Intelligence. The mix creates an end-to-end solution for diagnosis of sleep apnea, accelerated patient setup and resupply and proper data management to increase the adherence rate to 80%, he says. In this Vanguards of Health Care episode, Farrell sits down with BI analyst Matt Henriksson for an in-depth interview about how the company started as a spinoff from Baxter to become the market leader in sleep-apnea treatments. Those include novel technologies such as the AirSense 11 continuous positive airway pressure (CPAP) device and n30i mask. Farrell believes the rise of GLPs will have a “Botox effect” on sleep apnea, as patients become more aware of the disease and doctors use all available tools, including ResMed's CPAP devices, to treat it.See omnystudio.com/listener for privacy information.

In this episode of the 10x Growth Strategies podcast, host Aarti Vijayaragavan converses with Urvashi Tyagi, CTO of Resmed, focusing on the pivotal role of Emotional Intelligence (EQ) in personal and professional growth. This conversation features the book " Emotional Intelligence" by Dr.Travis Bradberry and Dr.Jean Greaves. They explore how EQ helps in self-management and introspection, and its influence in organizational leadership. Urvashi shares personal anecdotes, illustrating the impact of EQ on her career and personal life, while highlighting vital skills like self-awareness, social awareness, and relationship management. The discussion touches upon Urvashi's learnings from the book 'Emotional Intelligence' and its companion read 'Power' by Jeffrey Pfeffer, emphasizing that empathetic leadership fosters influence and empowerment.  Topics: 00:00 Introduction to Emotional Intelligence 01:23 Meet Urvashi Thyagi: A Leader in Digital Transformation 02:21 The Impact of Emotional Intelligence on Personal and Professional Life 02:48 Understanding and Developing EQ Skills 04:55 The Role of Self-Awareness in Emotional Intelligence 15:21 Strategies for Self-Management and Introspection 19:15 The Power of Influence and Empathetic Leadership 25:30 Building and Maintaining Relationships 30:37 Key Takeaways and Final Thoughts

In this week's episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of autonomous surgery. Still early goings on, but Damiano paints and interesting picture of the future. If you want to see the future register at West.DeviceTalks.com. Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life's healthcare experiences into a love of the industry and a drive to help. Anyone who wants to help should go to EnvisionMedtech.org. MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers – Surgical Robotics, Medtronic, ResMed, Layoffs and, of course, Baxter Healthcare. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network so you don't miss an episode of this or other industry-leading podcasts.

Today's guest is Urvashi Tiyagi, Advisor and Former CTO at ResMed. Urvashi joins us on today's podcast with Emerj Senior Matthew DeMello to discuss the unique challenges healthcare leaders face in driving software development efficiencies for medical devices and customer-facing mobile applications. As the med tech industry strives to balance innovation with regulatory compliance, many companies find themselves navigating complex approval processes that can delay product launches and stifle progress. This episode is sponsored by Pieces. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Daniel Eckert und Holger Zschäpitz über eine Spielverderberin bei Adidas, eine Hedgefonds-Attacke bei Ubisoft und den Ritterschlag von Palantir. Außerdem geht es um Sartorius Vz., Alphabet (Google), AT&T, Microsoft, IBM, Oracle, Amazon, ARM Holding, ResMed, Invesco EQQQ Nasdaq-100 thesaurierend (WKN: A2N6RV), WisdomTree NASDAQ 100 3x Daily Leveraged ETF (WKN: A3GL7E). Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Justin Nielsen and Alissa Coram walk through this week's technical action and stocks to watch in the Friday extended version of Stock Market Today.

Anna Bergevin, Sr. Product Manager at ResMed, brings her honest no-bs takes about data product management work and who should be doing it. We will discuss her path into data product management and how she is using AI to be productive and try new things!

Anna Bergevin, Sr. Product Manager at ResMed, brings her honest no-bs takes about data product management work and who should be doing it. We will discuss her path into data product management and how she is using AI to be productive and try new things!

Listen & subscribe on Apple, Google, Spotify, and other platforms. Welcome everyone to the weekly San Diego Tech News by Neal Bloom and Fred Grier from Fresh Brewed Tech. I'm Neal Bloom from Fresh Brewed Tech, the Tacos and Tech Podcast, and Interlock Capital. I'm Fred Grier, journalist and author of The Business of San Diego substack. I wrote about the tech industry for the San Diego Business Journal for two years. I covered the ins-and-outs of the startup world for much of that time, breaking news on IPOs, fundraising rounds, and M&A. Promote the show:  Before we dive in, we wanted to ask our listeners and SD Tech fans to help us grow the show, leave a review and share with one other person who should be more plugged in with the SD Tech Scene. Thank you for the support and for helping us build the San Diego Startup Community. 8/14 Avalon BioVentures Startup Acquired for 1.3B Earnings Season Read Out Qualcomm up 20% Resmed up 32% Sempra up 5%   San Diego Angel Conference moving to SDSU TuSimple visit EvoNexus Partners with Healthcare Companies to Accelerate Startups Metropolis IQ launches    Events – For full list – check The Social Coyote Carlsbad Life in Action Cleantech debrief NuFund Summer Social debrief CEO Retreat in Valle de Guadalupe by SVB, DLA Piper, and  Aug 21 - North County SD Startup Mixer Aug 22 - EDC Summer BashAug 26 - Carlsbad Life Science Gathering at Thermo Fisher Sept 6 - SD Founders Hike Sept 12 - Wharton Biotech panel Sept 16 - Evonexus Demo Day Sept 19 - Dev & Data Night x CTO Talks at Seismic Sept 23 - Pitch Deck Workshop for SD Startups Sept 23 - Carlsbad Tech Gathering at Shipcalm Sept 24 - Connect Innovation Day Oct 4 - SD Founders Hike Oct 20-22 - Stocktoberfest Oct 21-25 - San Diego Startup Week

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über zwei Nachrichten aus der Rüstungs-Branche, den Chipotle-Boom bei Starbucks und den neuen Mut der Regulatoren im Umgang mit den Tech-Giganten. Außerdem geht es um ResMed, Eli Lilly, Novo Nordisk, Burger King, Coca Cola, Starbucks, Chipotle Mexican Grill, Rheinmetall, Renk, Volkswagen, Google, Meta, Bytedance, Alphabet, Amazon und Apple. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch.  Das Buch zum Podcast? Jetzt lesen.  Die Deutsche Telekom mag Fußball. Eli Lilly und Duolingo mögen Wachstum. Under Armour und Beyond Meat mögen Restrukturierungen. Bumble und Dutch Bros. mochte gestern niemand. Die Abnehmspritzen von Eli Lilly und Novo Nordisk helfen auch gegen Schlafapnoe. Die Meldung hat ResMed (WKN: 895878) zeitweise massiv ins Minus geschickt. Hat die Börse übertrieben? Wir klären auf. Gasturbinen von Siemens Energy verkaufen sich grad sehr gut. Der Rest leider nicht. Ist Mitsubishi Heavy Industries (WKN: 853314) damit die bessere Aktie? Diesen Podcast vom 09.08.2024, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you'll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.

Medical device maker Resmed reports its earnings and signals potential partnerships with big tech. Rhayna Bosch talks to ResMed CEO Mick Farrell. Meanwhile – global share markets come crashing down – and Mahjabeen Zaman, the head of FX Researxch at ANZ Babnk says the ASX200 is clocking its WORST single trading day in 16 months.

ResMed has had the market on sleep apnea cornered for a while, but new weight-loss drugs might be creeping in. We look at what could change based on recent studies and some other businesses that have established lifelong customers. (00:21) Bill Barker and Dylan Lewis discuss: - How weight-loss drugs like Eli Lilly's Zepbound might be coming for ResMed and the sleep apnea market. - RXO take a bigger piece of the brokered transportation market, scooping up Coyote Logistics from UPS. - Target and Shopify linking up for a win-win partnership. (13:02) Tim Beyers and Ricky Mulvey discuss the value of lifetime-customer relationships, why they're huge for the likes of Apple, and Costco, and one lesser-known name that may have one too. Companies discussed: LLY, NVO, RMD, SPOT, AAPL, SNOW Host: Dylan Lewis Guests: Tim Beyers, Tim Beyers, Ricky Mulvey Producer: Ricky Mulvey Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Want to shift from managing people to building a culture & a team?In this episode of The Business Ownership Podcast I interviewed Jason Scott.J. Scott, a talentless, real-life anti-hero who doesn't just talk the talk, he walks the walk. Growing up in the streets of Los Angeles with less-than-ideal parents, J. learned early on that actions speak louder than words.J. Scott is the epitome of the anti-thought leader, proving that leadership isn't about being the most talented or successful person on the team. It's about helping your team members define and deliver success. If you surround yourself with talented people and inspire them to reach for THEIR potential, the leader doesn't need to be talented. They just have to play for the team. J. Scott is a regular guy who's proven that actions speak louder than words.Jason has spent over 20 years leading global transformational efforts for DirecTV, Trader Joe's, Blizzard Entertainment, RIOT Games, Sony Pictures, ResMed, AAG, Universal Music Group, Remitly, and others. He is the author of two Amazon-bestselling books “It's Never Just Business: It's About People” and “The Irreverent Guide to Project Management, An Agile Approach to Enterprise Project Management.” Jason is a sought-after keynote speaker, with 5-star reviews for his unique, people-centric, and outcome-obsessed approach to change that has generated breakthrough results and created meaningful jobs. His passion to mentor and training a new generation of leaders led him to start the Transformational Leadership Academy where he leads a 14-week certification program. Learn how to build a high-performing team. Check this out!Show Links:Jason Scott LinkedIn: https://www.linkedin.com/in/jasonscottJason Scott Website: https://www.jasonscottleadership.com/120VC Website: https://www.120vc.com/120VC YouTube Channel: https://www.youtube.com/channel/UCTqPCasdYzfsJ7nV61KWSqQBook a call with Michelle: https://www.AwarenessStrategies.com/m30Join our Facebook group for business owners to get help or help other business owners! The Business Ownership Group - Secrets to Scaling: https://www.facebook.com/groups/businessownershipsecretstoscalingLooking to scale your business? Get free gifts here to help you on your way: https://www.awarenessstrategies.com/

Bareeq Barqawi, DEI talent development analyst at Reed Smith, is joined by Sarah Hassaine, head of global diversity and inclusion at ResMed, to explore Sarah's remarkable journey and groundbreaking work in the field of diversity and inclusion advocacy. As April marks National Arab American Heritage Month, Sarah shares personal insights on how her cultural background has shaped her approach to fostering inclusion both personally and professionally. From championing health equity to addressing gender disparities and advocating for marginalized communities, Sarah offers practical strategies and invaluable advice for individuals and organizations seeking to drive positive change in their spheres of influence. Listen to this episode to gain valuable insights into the transformative power of inclusive leadership. ----more---- Transcript: Intro: Welcome to the Reed Smith podcast, Inclusivity Included: Powerful Personal Stories. In each episode of this podcast, our guests will share their personal stories, passions and challenges, past and present, all with the goal of bringing people together and learning more about others. You might be surprised by what we all have in common, inclusivity included.  Bareeq: Welcome to Inclusivity Included, the Reed Smith DEI podcast. I'm your host Bareeq Barqawi today. In honor of April being Arab American Heritage Month, we have the privilege of speaking with Sarah Hassaine, the head of global diversity and inclusion at ResMed and a trailblazer in the realm of diversity and inclusion advocacy. Before we delve into our discussion, I'd like to introduce our esteemed guests to our listeners. Sarah has is a dynamic leader with a decade long track record in driving global diversity and inclusion initiatives. Currently leading a global team at ResMed, she consults, advises, and upskills leaders worldwide, designs and delivers in-house D&I trainings and evaluates policies to drive inclusion. Notable achievements include expanding Resmed's ERGs or employee resource groups from 4 to 17, increasing self ID percentages by 4% and spearheading initiatives to improve representation and advocate for accessibility. Sarah brings over 20 years of management experience with a focus on HR initiatives recognized as San Diego businesswoman of the year in 2022. She holds an MBA from Wharton Business School and outside of work, she enjoys traveling, speaking three languages and finds relaxation in sunny beach days with a good book. Today, she joins us to share her insights and experiences. Sarah, welcome to the podcast.  Sarah: Thank you. It's so good to be here. Thanks for having me.  Bareeq: Of course. I'm going to dive right in for the sake of time. Sarah as an Arab American, how has your cultural background influenced your approach to diversity and inclusion advocacy, both personally and professionally?  Sarah: Yeah, And I'm really excited and happy that we're talking about the Arab American identity. Growing up, you're, you were othered as Arab Americans. So it has helped me across my career because the beautiful thing about being an inclusion and diversity leader is that you're navigating a lot of conversations around people feeling othered, and it's any category, right? Whether it's a parent, a caregiver, a veteran, a reservist, a lot of us experience that and as an Arab American, our identity is not accounted for, right? We're, you know, we're in the Census in the US, we're accounted for as white, but we're not treated as white. Oftentimes, our names are misspelled. Uh We get a lot of questions, small microaggressions, A lot of stereotypes get cast. And as someone who grew up, you know, an American grew up in this country, uh it is very hard to constantly feel like, oh, well, you know, you guys do this or you're, you're being othered all the time. So that has definitely helped with empathy and helping me understand the communities I work with and being able to relate and show that kind of validation to, to everyone else.  Bareeq: Wonderful. As an Arab American myself, I can, I can only relate to it because I, I always say when people ask why we got into this line of work, I say, well, being excluded, majority of my life has, has uh made me want to have others avoid this feeling um and be as inclusive as we possibly can be. So, thank you for that. So can you share actually a specific moment or experience that was pivotal in your transition into the realm of inclusion and diversity advocacy?  Sarah: Yeah. So I was supporting a recruiting team uh in a past life at a, a large company. And what we started seeing organically, right was that we got less female applicants, we got less women engaging with us at conference booths and we really didn't have any women on the team. And it started kind of, you know, being this issue that the hiring managers, like we, you know, we're seeing other women going to other companies, but they're not coming here. And why is that? And we had to look inward and understand that our marketing material, the language, we, we were interviewing, we would, you know, candidates, but they would be meeting with six males and then they meet the team. And so then it wasn't actually feeling like an attractive, safe space or there was no representation. And that's when it hit me that you can be supporting business culture, you can be supporting a business, you know, in many different facets. But if the business doesn't have a culture where employees feel like they can belong, that to me was the crux of what I wanted to do. It just hit me. I'm like, this is what I wanna do. It started with women, but then it became about everybody else and everything else. Um So that was kind of my, my point and that was about 10+ years ago. Uh when I got to start working on commercials and advertisements and conference booths and really thinking about what is inclusive engagement look like. How do you attract talent so that they know that when they come in there's, they're going to have a sense of belonging?  Bareeq: I love that. That's so insightful. I think that's such a great, I guess segue into my next question because, you know, we talk about gender disparity and addressing gender disparities is a crucial aspect of advocacy work. And you often talk about encountering challenges in attracting entertaining women in the workplace. What strategies do you find most effective in addressing such challenges?  Sarah: Yeah, there's a lot of data around how women that are mentored, usually they actually stay, they're more loyal to their companies and they actually have more growth trajectory. I will say mentorship and intentional leadership development programs are really important. The second thing I would also talk about is succession planning. Companies need to really think about, okay, here's our workforce in this department. What are we doing to make sure there's an equitable opportunity for promotion for assessment uh of performance of assigning stretch assignments. And so it needs to be a level playing field for everyone. So in order to really develop, make sure that your female population is having the same access as all other genders, you wanna make sure that you have strong succession planning retention methods like learning and development and mentorship.  Bareeq: Wonderful. Thank you so much for those examples. Actually, in dedication to promoting health equity within ResMed's diversity and inclusion initiatives, can you elaborate on your efforts in this area and how you ensure that health care solutions and services provided by ResMed are accessible and inclusive for diverse communities, including those that are often actually um marginalized and underserved?  Sarah: Yeah, there are a couple of answers I want to dive into for this one. So the first one is really thinking about the diversity in our mask and sleep trials in order for us to really think about a product that, you know, we sell worldwide in over 150 countries. So we wanna make sure that we're designing a mask um that has a rep representation already. So there's been a lot of intentionality around marketing to different communities that they participate in your sleep trials and your mask trials. So it has to start at the base of your product and with your research. We also have an entire department dedicated to medical research. And they have done a great job in terms of looking at the disparities between different populations, whether it's um African American women or Hispanic, like we start looking at a location. Uh So we, we, we address health equity in different ways. So there's the research component, there's the product component and then there's, you know, the fact that our business model is different in every country to your point about underrepresented or underserved communities, really making sure that, you know, our, that providers are telling patients, hey, get sleep tested or have you thought about looking into, you know, maybe going to a storefront? Right. So it depends where we're selling. Uh, it varies. In the United States, we go through HMEs. And so we want to make sure that that our doctors are getting our patients either at home sleep tests or getting them come to come into sleep clinics.  Bareeq: That's great, especially that partnership between the doctors and your organization, um and bringing them into that conversation. Um So I know your work extends beyond the corporate realm into advocacy for marginalized communities. Um Can you share about your involvement with refugee communities, orphans and economic inclusion in the San Diego community specifically?  Sarah: Yeah, you know, the refugee space is something very dear to my heart. When I graduated college, I worked in refugee camps in Lebanon um for different communities, African, Iraqi, Palestinian, Lebanese at the time. And then I went back when the war in Syria was happening in 2016. And I worked for a couple of weeks teaching English. So the first time I did socio-economic assessments to understand what the needs were. The gaps I should say, then I went back and taught English. So the way I look at refugee assistance or assimilation is around empowerment. San Diego has one of the largest refugee communities in the United States. Um We have every community here possible; Burmese, Somali, Kurdish, Syrian, Iraqi, uh Bosnian. And growing up here, I saw the waves of communities come in. And so it was a lot around upskilling, trying to get jobs, trying to get the school, the kids to get, you know, um learn English, get mentors. So I partnered with Teach and Learn Literacy, which was actually an organization through the Arab American Anti Discrimination Committee and uh volunteered twice a week teaching a Syrian family of eight English and helping them get jobs. So I did that for a few years uh now from an economic inclusion lens as I grow in my career, I partner with different nonprofits. Um So there's like the United Women of South of East Africa, they have a community center, there's the Refugee Assistance Council. So there's, there are all these organizations that do that look for mentorships, they want internships for students. So there's a lot of opportunity for corporations like ResMed or others across San Diego. So we try to build bridges around access to information, access to jobs, to mentors. And that to me is really important to make sure that our talent in San Diego stays here, grows here, feels like the sense of belonging here. So that's uh that's kind of what I do outside of work.  Bareeq: No, I love that because it's, it's also a representative of the community within which you're you are working in and, and finding ways to actually include the community in, in the work that you're doing. And I think that's actually incredibly commendable. So thank you for sharing that. So I'm actually gonna just gonna dive into the next question, which actually has to do with this as well. And it combines a couple of things we already discussed, which is in promoting economic inclusion and pay equity, what are some practical steps organizations can take to achieve gender parity in the workplace? I know this is always, I guess like a hot topic when it comes to any really across all sectors. But I would love to hear your uh your insight on it.  Sarah: Yeah, you have to start with data, you have to start with an analysis. So my recommendation to those listening is to understand if your organization has done a pay equity analysis, um understand your your data breakdown, right within organizations, looking at the different gender breakdowns. Then you can start understanding whether you have a story or not, right? Oh, some companies will do that pay equity analysis and then they'll come back and realize, well, we've had, you know, we have this percentage of cases. It could be bad, it could be not bad, not as bad as you thought, right? But it's very, very important to start with data. So my recommendation is to understand your gender breakdowns within each business unit. And I don't necessarily, I'm not the biggest fan of setting exact goals like percentages like X percent. I think it's important to go to leaders and say, well, here's where you are right now and here's what the benchmark is in this organization. So if you're looking at a finance or you're looking at electrical engineering, the gender availability in the pool of talent is different to begin with. So you can't claim 50/50 when you don't even have 50% a female representation in electrical engineering, for example. So understanding what the benchmarks are, is really going to help you. And then you can kind of say Well, you know what, let's really try to build more of a robust pipeline. Let's be more intentional or let's sponsor this conference. So that's where you really need to start solution out. It's not a one size fits all for an entire company. You have to break down a company within the departments. And then you also need to think about the overall pay equity analysis and understanding what, where potential remunerations are and if you have to do any adjustments.  Bareeq: I really love that because you're also talking about kind of funneling it down to, to it's almost like a case by case basis, like looking at different departments or different for, let's say, let's say, for example, the legal industry, we look at different practice groups and what is the representation there to begin with before we kind of dive into what the data says. I think that's a really great point. So actually I had a question and this is going to be a little bit of a pivot. So we talk about the importance of stripping away assumptions and biases in this line of work. How can individuals and organizations actively to work toward this goal? I think it's something that I would say the word actively because it's a really a never ending process. Um But what are some, I guess tips and advice you have for people.  Sarah: You know, I see a lot of D&I leaders focusing on unconscious bias trainings and that's it's great, but they're not really proven to help or work. It is important to offer it and it's important to uh have frameworks in place. What I find more valuable is showing leaders framework so that they understand psychologically why we have built in biases. Biases are there. It's it's not good to shame anyone for having biases. So what I always do, my recommendation is to know how to navigate biases. So you need to look at each team and kind of think about, ok, talent acquisition, what are potential biases here? With resumes, here's what we could do to navigate this or with interviewing, here's what we can do to navigate biases. So kind of going back to the the gender equity, it's your solutions need to go, they are tailored to the part of the department or company that has built in biases, right? If we're talking in promotion season, uh what I've done at companies before where I am now and now is let's make sure you have that point, that person who's in the meetings to make sure that there are no biases in assessing talent. Let's make sure that you don't have any biases when you're discussing promotions. So that's, that's where it's really important is when you're having promotion conversations, a hiring conversations, development conversations. I will say, I think it's very important to repeat conversations around unconscious bias. I do this training at least twice a year globally and people show up and actually leaders ask for it. They're just like, can you come in and talk about it because biases show up even in the way we communicate. I mean, Bareeq, we started off this conversation talking about being Arab American. I can't tell you how many times people tell me, I don't look Arab like I don't even understand what that means. Right. So the biases are there. And I think the biggest thing we can also teach our employees is knowing how to navigate those conversations, in a safe way, right, as a coachable moment. You know, so that's where we don't want more microaggressions. We want safe conversations where people are learning from one another.  Bareeq: I couldn't agree with you more, especially about the repetition because I just learned in a change management workshop that something only sticks after it's been repeated to you seven times which, you know, and talking about bias, I agree. I've, I've always been of the mindset that I can't shame anyone for bias because I think bias is inherently human. Um And you can't, you know, human beings will have bias. It's really about providing, providing tool kits in order to create bias disruption. Um And that's something that I think is a, is a powerful tool to provide people and, and reminding them, you know, over the course of time like, hey, this is available and let's talk about it and kind of bring it to the forefront, especially in very pivotal moments in the company. So like when you talk about performance assessment or they're going into recruiting season or things like that, I think it's um it's always like an essential thing to keep it in mind. So I completely agree. Um So I had something about challenges that we, that we end up facing and overcoming. It's an inevitable part of this advocacy work. Can you share a challenging moment in your journey and how you overcame it?  Sarah: Only one?  Bareeq: I was about to say there's probably many but one that comes, yeah, whatever comes to mind.  Sarah: I mean, the biggest thing that comes to mind is, is budget, right? Resources. The biggest challenge I had was um being on D&I teams and not being funded, not given adequate support and being de prioritized. And I know um if there are any D&I leaders listening to this, I'm sure there are some heads nodding or uh it is the hardest thing because I don't believe that we are set up for successfully. Uh And so the, the, you know, the days I have very long days and the days where I end even more exhausted is because I felt like someone didn't show up to meeting or move me out again or delayed a solution. Uh that is hard. And the other hard part is when you know, you need support or you need head count or you need that, that money or you want to sponsor, it gets really hard when you want to sponsor something and you don't have money to do it. And so com companies need to be very committed if your company is saying that they're committed to D&I, well, you have to, you have to show up. Right. And so that's where I'll say the biggest challenges.  Bareeq: Yeah, I found that even, not just where I am currently but in other organizations I've worked for, it's, it's definitely a constant problem if either it's monetarily or like you said, having that support. And I found that kind of pivoting the conversation almost lately, especially like making it a business case brings some people to the table in a different way because they're like, oh, you know, I never thought of it this way. So it's almost like changing perspectives on people's approach to D&I. You, you sometimes hope it was, you know, people come into it like already being there, but to get people there, you kind of have to find different approaches I feel. And finally, as we wrap up, um so what advice would you give beyond what we've given, because this has been a wonderful key conversation, what would you give advice to individuals or organizations looking to become more active in promoting inclusion diversity within their spheres of influence?  Sarah: Just to make sure it's uh for companies, right?  Bareeq: Advice for, for companies, for individuals, you know, people that are working to become more influential in the organization.  Sarah: So for internal advocates or internal stakeholders and D&I leaders, there is the opportunity you there's to really understand the power of influence and persistence and no one can really succeed in D&I without that strategic business lens. Like you need to understand your business and by understanding the business, then you can adapt a conversation around. What does inclusion mean at this business? What does it mean? Whether for my products, for my people, for our policies? Uh So that's my biggest one for internal and then for companies, I will say it's very important that if your values call out inclusion, diversity, belonging, acceptance, accessibility, then you have to embed that across all your work streams. You have to really think about. It's not just a people practice, it's an every leader, every person practice.  Bareeq: Thank you so much. I love that because it's almost like building in the expectation in anything that you kind of approach within the company. I love that. Thank you so much, Sarah for sharing your valuable insights and experience with us today. It's been an honor having you on the podcast and we really, I think have taken away some wonderful, wonderful key tips and advice that we will definitely be using hopefully.  Sarah: This is a joy. Thank you so much, Bareeq for the opportunity.  Bareeq: Thank you. And that's all for today's episode of Inclusivity Included. Join us next time as we continue our exploration of diversity, equity and inclusion. Thank you for listening.  Outro: Inclusivity Included is a Reed Smith production. Our producers are Ali McCardell and Shannon Ryan. You can find our podcast on Spotify, Apple Podcasts, Google Podcasts, reedsmith.com, and our social media accounts.  Disclaimer: This podcast is provided for educational purposes. It does not constitute legal advice and is not intended to establish an attorney-client relationship, nor is it intended to suggest or establish standards of care applicable to particular lawyers in any given situation. Prior results do not guarantee a similar outcome. Any views, opinions, or comments made by any external guest speaker are not to be attributed to Reed Smith LLP or its individual lawyers.  All rights reserved. Transcript is auto-generated.